Motor function and dopamine release measurements in transgenic Huntington's disease model rats

Brain Research

Volumn 1450, Issue , 2012, Pages 148-156

  Ortiz, Andrea N ^a   Osterhaus, Gregory L ^a   Lauderdale, Kelli ^a   Mahoney, Luke ^b   Fowler, Stephen C ^b,c   Von Hörsten, Stephan ^d   Riess, Olaf ^e   Johnson, Michael A ^a,c  

^a Department of Chemistry   (United States)

^b Life Span Institute   (United States)

^c Neuroscience Program   (United States)

^d UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^e UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Behavior; Dopamine; Huntington's disease; Microelectrode; Transgenic; Voltammetry

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; AMPHETAMINE; CARBON FIBER; DOPAMINE; HOMOVANILLIC ACID;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; CYCLIC POTENTIOMETRY; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; ELECTROSTIMULATION; EXPERIMENTAL MODEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUNTINGTON CHOREA; MALE; MICROELECTRODE; MOTOR PERFORMANCE; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; RAT; RUNAWAY BEHAVIOR; STEREOTYPY; TRANSGENIC RAT; WILD TYPE;

AMPHETAMINE; ANIMALS; BEHAVIOR, ANIMAL; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOPAMINE; HUNTINGTON DISEASE; MOTOR ACTIVITY; RATS; RATS, TRANSGENIC;

RATTUS;

EID: 84863405511     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2012.02.042     Document Type: Article

References (39)

1. G.P. Bates, P.S. Harper, and L. Jones Huntington's Disease 2002 Oxford University Press Oxford
2. V.J. Bolivar, K. Manley, and A. Messer Early exploratory behavior abnormalities in R6/1 Huntington's disease transgenic mice Brain Res. 1005 1-2 2004 29 35
3. Brooks, S.P.; Janghra, N.; Workman, V.L.; Bayram-Weston, Z.; Jones, L.; Dunnett, S.B.; in press. Longitudinal analysis of the behavioural phenotype in R6/1 (C57BL/6J) Huntington's disease transgenic mice. Brain Res. Bull.
4. J.W. Callahan, and E.D. Abercrombie In vivo dopamine efflux is decreased in striatum of both fragment (R6/2) and full-length (YAC128) transgenic mouse models of Huntington's disease Front Syst Neurosci. 5 61 2011 1 10
5. R.J. Carter, L.A. Lione, T. Humby, L. Mangiarini, A. Mahal, G.P. Bates, S.B. Dunnett, and A.J. Morton Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation J. Neurosci. 19 8 1999 3248 3257
6. J.R. Cooper, F.E. Bloom, and R.H. Roth The Biochemical Basis of Neuropharmacology 8th ed. 2003 Oxford University Press New York
7. Creese, I.; Iversen, S.D.; 1975. The pharmacological and anatomical substrates of the amphetamine response in the rat. Brain Res. 83, 419-436.
8. S.W. Davies, M. Turmaine, B.A. Cozens, M. DiFiglia, A.H. Sharp, C.A. Ross, E. Scherzinger, E.E. Wanker, L. Mangiarini, and G.P. Bates Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation Cell 90 1997 537 548
9. S.W. Davies, M. Turmaine, B.A. Cozens, A.S. Raza, A. Mahal, L. Mangiarini, and G.P. Bates From neuronal inclusions to neurodegeneration: neuropathological investigation of a transgenic mouse model of Huntington's disease Philos. Trans. R. Soc. Lond. B Biol. Sci. 354 1999 981 989
10. A. Denker, and S.O. Rizzoli Synaptic vesicle pools: an update Front. Synaptic Neurosci. 2 2010 1 12
11. J.F. Fischer, and A.K. Cho Chemical release of dopamine from striatal homogenates: evidence for an exchange diffusion model J. Pharmacol. Exp. Ther. 208 1979 203 209
12. S.C. Fowler, B.R. Birkestrand, R. Chen, S.J. Moss, E. Vorontsova, G. Wang, and T.J. Zarcone A force-plate actometer for quantitating rodent behaviors: illustrative data on locomotion, rotation, spatial patterning, stereotypies, and tremor J. Neurosci. Methods 107 2001 107 124
13. S.C. Fowler, B. Birkestrand, R. Chen, E. Vorontsova, and T. Zarcone Behavioral sensitization to amphetamine in rats: changes in the rhythm of head movements during focused stereotypies Psychopharmacology (Berl) 170 2 2003 167 177
14. S.C. Fowler, J.W. Pinkston, and E. Vorontsova Clozapine and prazosin slow the rhythm of head movements during focused stereotypy induced by d-amphetamine in rats Psychopharmacology (Berl) 192 2 2007 219 230
15. S.C. Fowler, B.R. Miller, T.W. Gaither, M.A. Johnson, and G.V. Rebec Force-plate quantification of progressive behavioral deficits in the R6/2 mouse model of Huntington's disease Behav. Brain Res. 202 1 2009 130 137
16. C.R. Gerfen The neostriatal mosaic: compartmentalization of corticostriatal input and striatonigral output systems Nature 311 5985 1984 461 464
17. M.A. Hickey, G.P. Reynolds, and A.J. Morton The role of DA in motor symptoms in the R6/2 transgenic mouse model of Huntington's disease J. Neurochem. 81 2002 46 59
18. M.A. Johnson, V. Rajan, C.E. Miller, and R.M. Wightman DA release is severely compromised in the R6/2 mouse model of Huntington's disease J. Neurochem. 97 2006 737 746
19. Kelly, P.H.; Seviour, P.W.; Iversen, S.D.; 1975. Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Res. 94, 507-522.
20. C.M. Kosinski, J.H. Cha, A.B. Young, L. Mangiarini, G. Bates, J. Schiefer, and M. Schwarz Intranuclear inclusions in subtypes of striatal neurons in Huntington's disease transgenic mice Neuroreport 10 1999 3891 3896
21. J.C. Kraft, G.L. Osterhaus, A.N. Ortiz, P.A. Garris, and M.A. Johnson In vivo DA release and uptake impairments in rats treated with 3-nitropropionic acid Neuroscience 161 3 2009 940 949
22. N.Y. Liang, and C.O. Rutledge Evidence for carrier-mediated efflux of dopamine from corpus striatum Biochem. Pharmacol. 31 1982 2479 2484
23. M.S. Levine, C. Cepeda, M.A. Hickey, S.M. Fleming, and M.F. Chesselet Genetic mouse models of Huntington's and Parkinson's diseases: illuminating but imperfect Trends Neurosci. 27 11 2004 691 697 Review
24. H.G. Lüesse, J. Schiefer, A. Spruenken, C. Puls, F. Block, and C.M. Kosinski Evaluation of R6/2 HD transgenic mice for therapeutic studies in Huntington's disease: behavioral testing and impact of diabetes mellitus Behav. Brain Res. 126 1-2 2001 185 195
25. L. Mangiarini, K. Sathasivam, M. Seller, B. Cozens, A. Harper, C. Hetherington, M. Lawton, Y. Trottier, H. Lehrach, S.W. Davies, and G.P. Bates Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice Cell 87 1996 493 506
26. D.P. McGowan, W. van Roon-Mom, H. Holloway, G.P. Bates, L. Mangiarini, G.J. Cooper, R.L. Faull, and R.G. Snell Amyloid-like inclusions in Huntington's disease Neuroscience 100 2000 677 680
27. L.B. Menalled, and M.F. Chesselet Mouse models of Huntington's disease Trends Pharmacol. Sci. 23 1 2002 32 39 Review
28. L.B. Menalled Knock-in mouse models of Huntington's disease NeuroRx 2 3 2005 465 470 Review
29. K.E. Moore The actions of amphetamine on neurotransmitters: a brief review Biol. Psychiatry 12 1977 451 462
30. H.P. Nguyen, P. Kobbe, H. Rahne, T. Wörpel, B. Jäger, M. Stephan, R. Pabst, C. Holzmann, O. Riess, H. Korr, O. Kántor, E. Petrasch-Parwez, R. Wetzel, A. Osmand, and S. von Hörsten Behavioral abnormalities precede neuropathological markers in rats transgenic for Huntington's disease Hum. Mol. Genet. 15 21 2006 3177 3194
31. B. Naver, C. Stub, M. Møller, K. Fenger, A.K. Hansen, L. Hasholt, and S.A. Sørensen Molecular and behavioral analysis of the R6/1 Huntington's disease transgenic mouse Neuroscience 122 4 2003 1049 1057
32. A.N. Ortiz, B.J. Kurth, G.L. Osterhaus, and M.A. Johnson Dysregulation of intracellular DA stores revealed in the R6/2 mouse striatum J. Neurochem. 112 3 2010 755 761
33. A.N. Ortiz, B.J. Kurth, G.L. Osterhaus, and M.A. Johnson Impaired DA release and uptake in R6/1 Huntington's disease model mice Neurosci. Lett. 492 1 2011 11 14
34. A. Petersén, Z. Puschban, J. Lotharius, B. NicNiocaill, P. Wiekop, W.T. O'Connor, and P. Brundin Evidence for dysfunction of the nigrostriatal pathway in the R6/1 line of transgenic Huntington's disease mice Neurobiol. Dis. 11 1 2002 134 146
35. S.O. Rizzoli, and W.J. Betz Synaptic vesicle pools Nat. Rev. Neurosci. 6 2005 57 69
36. E. Scherzinger, R. Lurz, M. Turmaine, L. Mangiarini, B. Hollenbach, R. Hasenbank, G.P. Bates, S.W. Davies, H. Lehrach, and E.E. Wanker Huntingtin-ended polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo Cell 90 1997 549 558
37. E.J. Slow, J. van Raamsdonk, D. Rogers, S.H. Coleman, R.K. Graham, Y. Deng, R. Oh, N. Bissada, S.M. Hossain, Y.Z. Yang, X.J. Li, E.M. Simpson, C.A. Gutekunst, B.R. Leavitt, and M.R. Hayden Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease Hum. Mol. Genet. 12 2003 1555 1567
38. L.H. Wang, and Z.H. Qin Animal models of Huntington's disease: implications in uncovering pathogenic mechanisms and developing therapies Acta Pharmacol. Sin. 27 10 2006 1287 1302 Review
39. S. von Hörsten, I. Schmitt, H.P. Nguyen, C. Holzmann, T. Schmidt, T. Walther, M. Bader, R. Pabst, P. Kobbe, J. Krotova, D. Stiller, A. Kask, A. Vaarmann, S. Rathke-Hartlieb, J.B. Schulz, U. Grasshoff, I. Bauer, A.M. Vieira-Saecker, M. Paul, L. Jones, K.S. Lindenberg, B. Landwehrmeyer, A. Bauer, X.J. Li, and O. Riess Transgenic rat model of Huntington's disease Hum. Mol. Genet. 12 6 2003 617 624